Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition - Test2 - elhamkhani - TriplyDB

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

http://www.wikidata.org/entity/Q33801982

about

Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer

P2860

Q47631097-EE3FEBE1-E34E-493E-BAE5-A50A48DF8AC3 Q58700431-BA03C278-DF36-482C-8006-CD54442CD8FB

P2860

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

http://www.wikidata.org/entity/Q33801982

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Platinum-containing compound p ...... through proteasome inhibition

@ast

Platinum-containing compound p ...... through proteasome inhibition

@en

type

label

Platinum-containing compound p ...... through proteasome inhibition

@ast

Platinum-containing compound p ...... through proteasome inhibition

@en

prefLabel

Platinum-containing compound p ...... through proteasome inhibition

@ast

Platinum-containing compound p ...... through proteasome inhibition

@en

P1433

Q33801982-2985DD62-3CE8-4180-8E52-981BF7B16A14

P1476

Q33801982-E744FDF1-2607-453A-AE11-5D8BB2E58D18

P2093

Q33801982-05BB2151-1515-40D1-9347-813225273C61

Q33801982-1D1C71E7-8459-44BE-9C16-BDC0FA66F761

Q33801982-3120F79A-66F9-4E0E-AC1E-E6E2C29F4D1C

Q33801982-34014755-7C62-421E-92FD-0AEE5543F3C8

Q33801982-46B98FCA-08DE-4AF3-8F29-7491ABD48FF3

Q33801982-5BA3FB5E-E2AE-4E5B-8AF9-37DC419337CB

Q33801982-6D4CC1A2-3329-427F-BF5F-C6DC8DCDA2F0

Q33801982-7646394B-BB2E-4C1A-8B58-704C8B90B079

Q33801982-81AB9DC8-690F-4969-8901-E97D0EB3A1D1

Q33801982-996ECBEC-EE61-430D-BA79-C18B365BC054

P2860

Q33801982-00637A9E-49C1-4551-B240-EE4012A90ED4

Q33801982-111BD37D-D773-4EE8-A9C1-AB856CBBDE33

Q33801982-17A4F4AD-6A73-4E2C-B2F1-1F5351DAE1FC

Q33801982-17F7EADC-191A-4237-B15A-958563FC8777

Q33801982-1F6D3C3F-6944-4424-BD97-339122C80CC5

Q33801982-2001338D-A069-4712-A29A-289DB9E6F86F

Q33801982-21BF5847-570D-41F5-9193-B9BFCE9AF61A

Q33801982-23290FB1-CF02-40FE-9702-C068E4F838B5

Q33801982-244E7083-FCB9-4271-B2AF-803E3C907376

Q33801982-27F20AD6-9072-4AC0-8814-85334E6606B0

P2888

Q33801982-57B86D38-7827-4764-8CF0-C71C96ECA7C9

P304

Q33801982-6F0EB12B-45B5-45E0-9429-BA4A25EA3B75

P31

Q33801982-8ABEBF7E-6681-457F-8D00-27B0B1B25010

P356

Q33801982-48A76019-83E9-4EAB-A6C4-13DC1128CABA

P433

Q33801982-9D273DDC-4139-4188-A0A5-21142DC40144

P478

Q33801982-2C98B33F-C96C-476B-A7BD-4B6FA6F26E76

P577

Q33801982-733F6ED9-C411-41D3-A253-771E9796DAE7

P6179

Q33801982-658C84AC-6547-4D41-A171-BF33E891094D

P698

Q33801982-DC725B9A-1CDD-4345-A7E7-4D115625359F

P932

Q33801982-557D3343-4D21-4F12-B01C-9F2AAB037611

P356

S13046-017-0547-8

P1433

Journal of Experimental & Clinical Cancer Research

P1476

Platinum-containing compound p ...... through proteasome inhibition

@en

P2093

Dhivya Rajakumar

http://www.w3.org/2001/XMLSchema#string

Hongbiao Huang

http://www.w3.org/2001/XMLSchema#string

Jianyu Cai

http://www.w3.org/2001/XMLSchema#string

Jinbao Liu

http://www.w3.org/2001/XMLSchema#string

Ni Liu

http://www.w3.org/2001/XMLSchema#string

Ningning Liu

http://www.w3.org/2001/XMLSchema#string

Qi Yin

http://www.w3.org/2001/XMLSchema#string

Qingxia Wu

http://www.w3.org/2001/XMLSchema#string

Qirong Wen

http://www.w3.org/2001/XMLSchema#string

Xiaohong Xia

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of cell cycle progression and gene expression by H2A deubiquitination

Cancer statistics, 2008

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance

Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data.

Role of autophagy in cisplatin resistance in ovarian cancer cells

A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability.

The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts.

Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity

P2888

s13046-017-0547-8

P304

79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-017-0547-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086046770

http://www.w3.org/2001/XMLSchema#string

P698

28619062

http://www.w3.org/2001/XMLSchema#string

P932

5471884

http://www.w3.org/2001/XMLSchema#string